A. Visvikis

Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone

C. Christodoulou, A. Pervena, G. Klouvas et al. · Oncology · 2009 · 234 citations

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

Aristotelis Bamias, Urania Dafni, Alexandra Karadimou et al. · Annals of Oncology · 2012 · 97 citations

Surgical Oncology, Urology, He 16/03 +7

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group

D. Pectasides, Gerasimos Aravantinos, Haralabos P. Kalofonos et al. · Annals of Oncology · 2001 · 37 citations · Full text

Second-line Treatment, Metastatic Urothelial Cancer, Urology +6

Combination Chemotherapy With Carboplatin, Docetaxel, and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase II Study

D. Pectasides, A. Aspropotamitis, A. Halikia et al. · Journal of Clinical Oncology · 1999 · 27 citations

Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial

Dimitrios Pectasides, A. Visvikis, A. Aspropotamitis et al. · European Journal of Cancer · 2000 · 26 citations

Urology, Oncology, Phase Ii Trial +5